New ALS drug stabilizes decline with a trend toward improved strength and mobility for some

Historically, people with amyotrophic lateral sclerosis (ALS) experience a relentless decline in neurological function that eventually robs them of the ability to move, speak, eat or breathe. Now, researchers from Washington University School of…

Continue Reading

News Source: medicalxpress.com